Maple Grove, MN and North Augusta, SC – August 7, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and AmbioPharm, Inc. (AmbioPharm) today announced that the companies have entered into a partnership agreement to develop and market ... Read More
Eligible Patients Pay $0 per Prescription* for Upsher-Smith Migraine Medications
Maple Grove, MN – June 23, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its continued commitment to people who suffer from migraines during National Migraine ... Read More
Company Strengthens Its Generic Portfolio with Rapid Product Expansion
Maple Grove, MN – February 19, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its generic portfolio with the recent launch of three ... Read More
Awardees Selected for Their Commitment to Patients and Effort in Advancing the Pharmacy Profession
Maple Grove, MN – February 18, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) are ... Read More
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending the 2019 Annual Meeting of the American Epilepsy Society (AES) December 6-10, 2019 in Baltimore, MD. Meeting attendees are encouraged to visit booth #526 ... Read More
Program Provides Access and Affordability for Patients Seeking Treatment for Acute Migraine
Maple Grove, MN – November 18, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added Zembrace® SymTouch® (sumatriptan) Injection 3 mg ... Read More
Left to Right: NCPA President Bill Osborn,PharmD; Steve Moore, PharmD (winner); and Mike McBride of Upsher Smith
NCPA AWARD SPONSORED BY UPSHER-SMITH FOR ELEVENTH CONSECUTIVE YEAR
Maple Grove, MN – October 29, 2019 – Upsher-Smith Laboratories, LLC ... Read More
VISIT BOOTH #414 TO LEARN ABOUT VIGADRONE® (VIGABATRIN) FOR ORAL SOLUTION AND ITS SAVINGS AND SUPPORT PROGRAM
Maple Grove, MN – October 22, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be attending ... Read More
Maple Grove, MN – September 20, 2019 – UpsherSmith Laboratories, LLC (Upsher-Smith) today announced that executives from its parent company, Sawai Pharmaceutical Co., Ltd. (Sawai) including Sawai’s President, Mitsuo Sawai and General Manager of External ... Read More
STRATEGIC ACQUISITION OF TOSYMRA™ (SUMATRIPTAN) NASAL SPRAY AND ZEMBRACE® SYMTOUCH® (SUMATRIPTAN) INJECTION FURTHER EXPANDS AND DIVERSIFIES COMPANY’S PORTFOLIO
Maple Grove, MN – July 20, 2019 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has completed ... Read More
